Page last updated: 2024-08-18

methyleugenol and Cancer of Cervix

methyleugenol has been researched along with Cancer of Cervix in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, HY; Ding, Y; Shen, YL; Shi, S; Wang, L; Yi, JL; Zhu, J	1

Other Studies

1 other study(ies) available for methyleugenol and Cancer of Cervix

Article	Year
Myricetin and methyl eugenol combination enhances the anticancer activity, cell cycle arrest and apoptosis induction of cis-platin against HeLa cervical cancer cell lines. International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 3; Cell Cycle; Cell Cycle Checkpoints; Cell Proliferation; Cell Survival; Cisplatin; Drug Combinations; Drug Interactions; Drug Synergism; Eugenol; Female; Flavonoids; HeLa Cells; Humans; Uterine Cervical Neoplasms	2015

Article

Year

Myricetin and methyl eugenol combination enhances the anticancer activity, cell cycle arrest and apoptosis induction of cis-platin against HeLa cervical cancer cell lines.

International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:2

Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 3; Cell Cycle; Cell Cycle Checkpoints; Cell Proliferation; Cell Survival; Cisplatin; Drug Combinations; Drug Interactions; Drug Synergism; Eugenol; Female; Flavonoids; HeLa Cells; Humans; Uterine Cervical Neoplasms

2015